• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Oncology Technology Solutions, Services Impacting Patients and Providers

Value-Based Care’s Story Will Turn in the 2020s

by Daniel Kus, VP of Pharmacy Services at Henry Ford Health System and Troy Polan, acting CEO of ExceleraRx Corp 04/20/2020 Leave a Comment

Value-Based Care’s Story Will Turn in the 2020s

Value-based care initiatives matured in recent years thanks to exciting new technology and influential policy changes. But the coming decade will see transformative changes that will eventually lead to a uniform realization of value-based care across the entire healthcare continuum. Specialty pharmacy represents one area of healthcare that is wholeheartedly welcoming a discussion about value. With the costs of six-figure specialty drugs and the number of patients using them continuing to
Read More

Biofourmis Acquires Digital Therapeutics Oncology Startup Gaido Health

by Fred Pennic 04/16/2020 Leave a Comment

Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health

What You Should Know: - Boston-based digital therapeutics startup Biofourmis acquires LA-based Gaido Health from Takeda Pharmaceuticals, in a strategic deal that expands Biofourmis’ portfolio in the oncology space. - Gaido Health—a digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm. - With Gaido Health’s and Biofourmis’ dual focus on remote monitoring with wearables
Read More

Analysis: Applying AI in the Fight Against The Coronavirus

by Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research 04/01/2020 Leave a Comment

The Many Faces of AI in Clinical Trials

Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More

TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?

by Simon Harris, Managing Director at Signify Research 03/09/2020 Leave a Comment

TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?

On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market: - The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio. - TeraRecon is an Advanced
Read More

The Many Faces of AI in Clinical Trials

by Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research 02/28/2020 Leave a Comment

The Many Faces of AI in Clinical Trials

AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs. The
Read More

4 Hospitals Leveraging Social Media to Improve Patient Engagement

by HITC Staff 02/27/2020 Leave a Comment

Can Healthcare Social Media Prevent Chronic Disease

Social media is an essential online marketing and outreach tool for any organization that wants to connect to the largest audience possible. However, health organizations — like hospitals — can face unique challenges in managing social media, which can make effectively leveraging these tools less straightforward. Many large hospitals have been successful in making social media work for them. As a result, they've provided a template that other healthcare
Read More

KLAS Names Epic, Pivot Point, Accenture Overall Best in KLAS 2020

by Fred Pennic 01/31/2020 Leave a Comment

Best in KLAS 2020

- Epic was named the top Overall Software Suite for the tenth consecutive year in the Best in KLAS 2020 Software & Services report. - Pivot Point Consulting, a Vaco Company, was named the top Overall IT Services Firm, edging out last year’s winner, Impact Advisors. - Accenture earned the award of top Overall Healthcare Management Consulting Firm.Today, KLAS Research announced released their annual Best in KLAS Software & Services that recognizes the leading vendors for solutions,
Read More

Notable Launches Observational Clinical Trial for Patients with Blood Cancer

by Fred Pennic 01/23/2020 Leave a Comment

Notable Launches Observational Clinical Trial for Patients with Blood Cancer

 - Notable launches The ANSWer Study, it's new observational clinical trial for patients with blood cancer and is currently enrolling patients.- The primary assessment is to establish a tumor registry with annotated clinical outcomes.Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling patients in its new observational clinical trial. The clinical trial will take place at
Read More

Personal Genome Diagnostics, Mayo Clinic Partner to Enhance Patient Care in Oncology

by Fred Pennic 01/08/2020 Leave a Comment

Personal Genome Diagnostics, Mayo Clinic Partner to Enhance Patient Care in Oncology

- Together, PGDx and Mayo Clinic will focus on technology optimization and clinical utility studies for liquid biopsy and tissue-based genomic applications.- The shared vision and overall goal for PGDx and Mayo Clinic is to improve patient care by advancing the capabilities of oncology diagnostics testing. Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced a strategic collaboration with Mayo Clinic to enhance the development of clinical diagnostic solutions for
Read More

Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019

by Fred Pennic 12/27/2019 Leave a Comment

Kareo Sells Managed Billing Services Business to Health Prime International

- From Google's acquisition of Fitbit to Philips acquisition of Carestream Health's health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter. Q1 M&A Activity Johnson & Johnson Acquires Auris Health for $3.4B to Expand Digital Surgery Portfolio Johnson & Johnson acquiresAuris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately-held developer of
Read More

Pages: Page 1 Page 2 Page 3 Page 4
  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 19
  • Go to page 20
  • Go to page 21
  • Go to page 22
  • Go to page 23
  • Interim pages omitted …
  • Go to page 28
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |